Skip to main content
Caplight Logo









Rivermark Medical

Rivermark Medical

Private
Milwaukee, WisconsinHealthcare & Life Scienceshttps://www.rivermarkmedical.com/

Last Round

Series D

May 13, 2026

Total Funding Raised

$54.2M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Rivermark Medical is a medical device company that develops minimally invasive therapies for restoring urinary function in patients suffering from benign prostatic hyperplasia.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

urology medical devicebenign prostatic hyperplasiaBPHurethral implantminimally invasive urologynitinol implantoutpatient urologyprostatic stenturology implantoffice-based procedureclinical trialurology hardwaremedtechurology startup

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Rivermark Medical Comparables

Compare Rivermark Medical with similar companies based on industry and business-model similarity.

Rivermark Medical comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Butterfly Medical
92%
Zenflow
92%
ProVerum Medical
92%

Rivermark Medical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series DMay 13, 2026
Series COct 10, 2024
Series BJul 31, 2023

Key People

Founding team and executive leadership

Adam Kadlec

President & CEO

Executive Team

MSF l l CEPA Peter Chouinard

Consulting CFO

Executive Team

Rivermark Medical Investors

Notable investors and investment history

Rivermark Medical investors
InvestorRounds
Time BioVenturesSeries C, Series D
American Century InvestmentsSeries D, Series C
Andera PartnersSeries D
Cadence Healthcare VenturesSeries B, Series C, Series D
Clarevia VenturesSeries D
Venture Investors Health FundSeries C
View VenturesSeries B, Series C, Series D

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 17, 2026

    Grew 20% QoQ, from 15 to 18 employees.

  • May 13, 2026

    $20M round led by Andera Partners

Rivermark Medical Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Rivermark Medical Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Rivermark Medical's valuation, stock price, and market status.

Firmographic Details

HeadquartersMilwaukee, Wisconsin
Employee Range18
Year Founded2021
Last FundingMay 13, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?